ArticlePloS one2022
HAPLN1 confers multiple myeloma cell resistance to several classes of therapeutic drugs.
Mailee Huynh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticlePloS one2022
Mailee Huynh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.